Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2026-08-31 16:11:56 ET · period of report 2026-08-27 · accession 0001622058-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 16:11 | 2026-08-27 | MEDP | Troendle August J. | Pres, CEO, Dir, 10% | S - Sale | $620.27 | -650 | 539.9K | -0.1% | -$403.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-27 | S | D | 650 | $620.27 | 539,894 | D | — | — | (F1) The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |